MedTrace Logo

Adjuvants for Bupivacaine in Brachial Plexus Block in Pediatrics

NCT06180941 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2023-12-26

No results posted yet for this study

Summary

Among paediatrics aging 3:12 who are going to have upper limb surgery,does adding clonidine to bupivacaine improve brachial plexus block outcome in comparison with magnesium sulfate with bupivacaine?

Conditions

  • Upper Limb Injury

Interventions

DRUG

magnesium sulfate.

magnesium sulfate as adjuvant to bupivacaine in supraclavicular brachial plexus block in pediatrics.

DRUG

clonidine.

clonidine as adjuvant to bupivacaine in supraclavicular brachial plexus block in pediatrics.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-31
Primary Completion
2024-06-30
Completion
2024-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06180941 on ClinicalTrials.gov